Cargando…
Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy
The pathogenesis of orbital Graves’ disease (GD), a process known as thyroid-associated ophthalmopathy (TAO), remains incompletely understood. The thyrotropin receptor (TSHR) represents the central autoantigen involved in GD and has been proposed as the thyroid antigen shared with the orbit that cou...
Autores principales: | Smith, Terry J., Janssen, Joseph A. M. J. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206614/ https://www.ncbi.nlm.nih.gov/pubmed/28096798 http://dx.doi.org/10.3389/fendo.2016.00167 |
Ejemplares similares
-
New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor
por: Smith, Terry J
Publicado: (2018) -
Insulin-Like Growth Factor Pathway and the Thyroid
por: Smith, Terry J.
Publicado: (2021) -
Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy
por: Smith, Terry J.
Publicado: (2020) -
Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy
por: Janssen, Joseph A.M.J.L., et al.
Publicado: (2021) -
Treating Thyroid Associated Ophthalmopathy in Pediatric Patients
por: Dong, Tianyu, et al.
Publicado: (2022)